Synairgen (SNG)

 

Latest News

Preliminary Results

RNS Number: 3540F Synairgen plc 17 May 2017 Press release Synairgen plc ('Synairgen' or the 'Company') Preliminary statement of results for the year ended 31 December 2016 Southampton, UK - 17 May 2017: Synairgen (LSE: SNG), the respiratory drug discovery and development company, today announces its preliminary statement of audited results for the year en...

US tax reform plans and ex-dividends push FTSE lower

Investors were disappointed with a lack of detail on US President Donald Trump's tax reform plans, while stocks going ex-d...

Synairgen updates on AZD9412

Synairgen (SNG) said its AZD9412 study did not meet AstraZeneca's predefined criteria for progression, and it had elected ...

AZD9412 Update

RNS Number: 4767D Synairgen plc 27 April 2017 Press release Synairgen plc ('Synairgen' or the 'Company') AZD9412 Update Cold infections did not affect trial patients' asthma in the INEXAS study as much as predicted, meaning that the drug's effects on severe exacerbations could not be determined Treatment with AZD9412 switched on antiviral responses in the lu...

All News

DateHeadlineSource
17-05-17Preliminary ResultsRNS
27-04-17US tax reform plans and ex-dividends push FTSE lower StockMarketWire
27-04-17Synairgen updates on AZD9412StockMarketWire
27-04-17AZD9412 UpdateRNS
27-03-17Holding(s) in CompanyRNS
13-03-17Holding(s) in CompanyRNS
10-03-17Additional Positive Data in Lung FibrosisRNS
17-01-17Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
12-10-16Synairgen updates on AZD9412StockMarketWire
12-10-16FTSE up on airlines, house builders after sluggish startStockMarketWire
12-10-16AZD9412 Clinical Trial UpdateRNS
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
17-05-16Posting of Annual Report and Notice of AGMRNS
21-04-16Holding(s) in CompanyRNS
23-03-16Synairgen options exercised StockMarketWire
23-03-16Exercise of OptionsRNS
22-03-16Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
22-03-16Positive LOXL2 resultsRNS
22-03-16Preliminary results for the year ended 31 Dec 2015RNS
03-03-16Notice of Preliminary ResultsRNS
16-11-15Adoption of FRS 101 - Reduced Disclosure FrameworkRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Directors' Share PurchaseRNS
28-10-15Grant of optionsRNS
16-09-15Synairgen swings to H1 pretax lossStockMarketWire
16-09-15Interim ResultsRNS
21-08-15Synairgen schedules interimsStockMarketWire
21-08-15Notice of Interim ResultsRNS

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory